| Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? |
| |
| 摘 要： | ![]()
|
| 收稿时间： | 2021-03-27 |
Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? |
| |
| Jalpa Devi,Aimun Raees,Amna Subhan Butt. Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?[J]. World journal of hepatology, 2022, 14(1): 158-167. DOI: doi:10.4254/wjh.v14.i1.158 |
| |
| Authors: | Jalpa Devi Aimun Raees Amna Subhan Butt |
| |
| Affiliation: | Jalpa Devi, Department of Gastroenterology, Liaquat University of Medical and Health Sciences, Jamshoro 74800, PakistanAimun Raees, Amna Subhan Butt, Department of Gastroenterology, Aga Khan University Hospital, Karachi 74800, Pakistan |
| |
| Abstract: | ![]()
Recently, a single letter change has taken the world by storm. A group of experts have developed a consensus to upgrade the term non-alcoholic fatty liver disease (NAFLD) to metabolic associated fatty liver disease (MAFLD), suggesting that MAFLD would more accurately reflect not only the disease pathogenesis but would also help in patient stratification for management with NAFLD. However, the difference of opinion exists, which has made the NAFLD vs MAFLD debate the current talk of the town. This review will focus on the plausibility and implications of redefining NAFLD as MAFLD. |
| |
| Keywords: | Non-alcoholic fatty liver disease Metabolic associated fatty liver disease Fatty liver disease Non-alcoholic fatty liver Review |
|
| 点击此处可从《World journal of hepatology》浏览原始摘要信息 |
